DEEPEXI TECH (01384): Hong Kong's Most Oversubscribed IPO with Six Top Global Long-Term Funds Participating

Stock News
10/27

The true test of a company’s appeal to global long-term funds lies not just in its fundamentals or sponsors but in the strength of its underwriters. DEEPEXI TECH (01384) has made waves by securing two of Hong Kong’s most sought-after underwriters—Huanghe Securities—as joint global coordinators for its IPO. This powerhouse duo, renowned for their recent blockbuster deal with Zhida Tech (which surged 190% on debut), has drawn heavyweight investors to DEEPEXI’s offering.

The IPO shattered records with over 7,500x oversubscription, raising HK$270 billion and becoming the most oversubscribed 18C tech listing this year. Institutional demand was equally frenzied, with participation from elite funds like VanCapital, BlackRock, Symmetry, Millennium, Schonfeld, Balyasny, D.E. Shaw, Orix, Ghisallo, and Jump Trading—six of the world’s top 10 long-term asset managers.

**Key Investors Spotlight**: - **BlackRock**, the world’s largest asset manager ($10 trillion AUM), focuses on long-term wealth-building. - **Balyasny** ($260 billion AUM) employs multi-strategy investing across equities and macro. - **D.E. Shaw** ($100+ billion AUM) pioneers quant-driven trading models. - **Millennium** ($100+ billion AUM) combines rigorous risk management with global opportunities. - **ORIX** ($100+ billion AUM) spans diverse sectors, from finance to renewable energy.

DEEPEXI’s allure stems from its "Data+AI" dual-engine strategy, mirroring Palantir’s trajectory. Its FastData (enterprise data intelligence) and FastAGI (AI solutions) platforms have driven rapid adoption in retail, manufacturing, and healthcare. Revenue skyrocketed 55.5% CAGR from 2022–2024 (RMB243 million), with H1 2025 sales up 118.4% YoY to RMB132 million. FastAGI alone surged 191%, now contributing 55.3% of total revenue.

With its record-breaking IPO and blue-chip backing, DEEPEXI is poised to capitalize on its "China’s Palantir" narrative, making its market debut one to watch.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10